Dr Reddy's Launches First Generic Pataday Extra Strength Eye Drops in US

• Dr Reddy's Laboratories has launched the first over-the-counter generic version of Pataday Extra Strength eye drops in the US.
• The product, olopatadine hydrochloride ophthalmic solution USP 0.7%, is approved by the US FDA.
• It offers temporary relief from itchy eyes caused by allergens like pollen and animal dander.
• This launch expands Dr Reddy's existing US OTC eye-care portfolio, which includes lower-strength olopatadine versions.
• The company's Pataday brand recorded US sales of approximately $69.9 million in 2025.

Why It Matters: Dr Reddy's is the first to market a generic Pataday Extra Strength eye drop in the US, expanding its OTC portfolio.